First, nanoparticle delivery of TP53 conjugated with poly (β-amino esters) into SCLC cells, demonstrated activity in controlling cancer cell growth both in vitro and in vivo [154], implying efficient uptake into tumor tissues. Here, TP53 is linked to neoplasm.